![Brilinta 90mg Tablet 180s - AstraZeneca | Know more about your medicines. World's biggest video library of medicines - medwiki.co.in Brilinta 90mg Tablet 180s - AstraZeneca | Know more about your medicines. World's biggest video library of medicines - medwiki.co.in](https://storage.googleapis.com/dawaadost.appspot.com/medwiki_products/medwiki_products_img_265458pAYyR.png)
Brilinta 90mg Tablet 180s - AstraZeneca | Know more about your medicines. World's biggest video library of medicines - medwiki.co.in
![Adenosine-Mediated Effects of Ticagrelor: Evidence and Potential Clinical Relevance | Journal of the American College of Cardiology Adenosine-Mediated Effects of Ticagrelor: Evidence and Potential Clinical Relevance | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/0bdde27a-3964-4988-926c-4febedacce59/gr2.jpg)
Adenosine-Mediated Effects of Ticagrelor: Evidence and Potential Clinical Relevance | Journal of the American College of Cardiology
![Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin | Stroke Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin | Stroke](https://www.ahajournals.org/cms/asset/777cc2ea-c195-4556-a749-3bb7ba764cc3/strokeaha.120.032239.fig03.jpg)
Ticagrelor Added to Aspirin in Acute Nonsevere Ischemic Stroke or Transient Ischemic Attack of Atherosclerotic Origin | Stroke
![Cas(274693-27-5), Ticagrelor-Aladdin, AR-C 126532XX; AZD 6140;AZD6140;AZD-6140;(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol, Cas(274693-27-5), Ticagrelor-Aladdin, AR-C 126532XX; AZD 6140;AZD6140;AZD-6140;(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol,](https://www.aladdin-e.com/media/catalog/product/cache/49efc48ad39f6e70be72d36ea561a565/T/1/T125095.png)
Cas(274693-27-5), Ticagrelor-Aladdin, AR-C 126532XX; AZD 6140;AZD6140;AZD-6140;(1S,2S,3R,5S)-3-[7-[[(1R,2S)-2-(3,4-Difluorophenyl)cyclopropyl]amino]-5-(propylthio)-3H-1,2,3-triazolo[4,5-d]pyrimidin-3-yl]-5-(2-hydroxyethoxy)-1,2-cyclopentanediol,
![Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans | Journal of the American College of Cardiology Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans | Journal of the American College of Cardiology](https://www.jacc.org/cms/asset/a7a9c084-1778-4d31-be40-8f54b1e8fbf2/gr4.jpg)
Ticagrelor Enhances Adenosine-Induced Coronary Vasodilatory Responses in Humans | Journal of the American College of Cardiology
![Preferred ACS Treatment Not Associated With Better Patient Outcomes In Contemporary Clinical Practice According To Recent Multi-National Observational Study – OHDSI Preferred ACS Treatment Not Associated With Better Patient Outcomes In Contemporary Clinical Practice According To Recent Multi-National Observational Study – OHDSI](https://www.ohdsi.org/wp-content/uploads/2020/10/Chan-graphic.png)
Preferred ACS Treatment Not Associated With Better Patient Outcomes In Contemporary Clinical Practice According To Recent Multi-National Observational Study – OHDSI
![CardsJC: Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes - ISAR-REACT 5 Trial - Cardionerds Twitter Journal Club CardsJC: Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes - ISAR-REACT 5 Trial - Cardionerds Twitter Journal Club](https://i0.wp.com/www.cardionerds.com/wp-content/uploads/2022/03/ISAR-REACT-5-Trial-Visual-Abstract-CardioNerds-CardsJC.png?ssl=1)
CardsJC: Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes - ISAR-REACT 5 Trial - Cardionerds Twitter Journal Club
![Antithrombotic Therapy After Acute Coronary Syndromes or Percutaneous Coronary Interventions in East Asian Populations | JACC: Asia Antithrombotic Therapy After Acute Coronary Syndromes or Percutaneous Coronary Interventions in East Asian Populations | JACC: Asia](https://www.jacc.org/cms/asset/0d47f853-7999-4128-bcf9-ba0cff8111a4/gr4.jpg)
Antithrombotic Therapy After Acute Coronary Syndromes or Percutaneous Coronary Interventions in East Asian Populations | JACC: Asia
![Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines | Gut Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines | Gut](https://gut.bmj.com/content/gutjnl/65/3/374/F1.large.jpg)
Endoscopy in patients on antiplatelet or anticoagulant therapy, including direct oral anticoagulants: British Society of Gastroenterology (BSG) and European Society of Gastrointestinal Endoscopy (ESGE) guidelines | Gut
![Ticagrelor Reduces Thromboinflammatory Markers in Patients With Pneumonia | JACC: Basic to Translational Science Ticagrelor Reduces Thromboinflammatory Markers in Patients With Pneumonia | JACC: Basic to Translational Science](https://www.jacc.org/cms/asset/c5ed37ac-905c-40f0-8713-a1da032c1652/fx1.jpg)